CCL2 and brain infarction: In the present study, both SGD and clopidogrel inhibited the inflammatory response arising from cerebral infarct and our results demonstrated unequivocally that SGD was a more potent inhibitor of the expression of IL-1β, TNF-α, and MCP-1 than clopidogrel.